The WHO Guideline Development Group of international experts noted that antibody drugs sotrovimab and casirivimab-imdevimab are not recommended for patients with COVID-19.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/bU40Evg
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» WHO 'strongly advises against' use of two COVID-19 antibody therapies: BMJ
https://ift.tt/Sw7jzRr
No comments:
Post a Comment